Clinical Opportunity
Vicus brings breakthrough therapies to patients that address serious unmet medical needs.
Improved treatments for advanced cancer patients with systemic inflammation represent a serious unmet medical need. Multiple studies have shown that these patients with systemic inflammation, as assessed by weight loss, have significantly reduced life expectancy across cancers types. In addition, these patients do not tolerate therapy, become disabled and require costly hospital care.
Prognostic Value of Weight Loss at Diagnosis
